Diagnostic accuracy of moray microforceps in pancreatic cystic lesions

Not Applicable

• Conditions: Health Condition 1: K862- Cyst of pancreas

• Registration Number: CTRI/2021/07/035260
• Lead Sponsor: Dr Praveer rai

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: Closed to Recruitment of Participants
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

1. Age over 18 years old

2. FNAofthe cystic fluid indicated during an endoscopic ultrasound examination

3. Abdominal CT and pancreatic MRI less than 3 months old, available

4. Pancreatic cyst unilocular or with a macrolocule in case of multilocular cyst, of size >= to 20 mmofmajor axis with a clean wall

Exclusion Criteria

1. Contraindication to performing an upper endoscopic ultrasound

2. Patient with known chronic calcifying pancreatitis, or suspected on the iconography available during the screening visit

3. Patient taking an antiplatelet, or anticoagulant therapy including anti-vitamin K, direct oral anticoagulant, or heparin. 4. Hemorrhagic disease, hemostasis and coagulation disorder (TP < 60%, TCA > 40 sec. and platelets < 60000/mm3), malignant hematopathy, chronic cirrhotic liver disease with Child Pugh B or C, acute or severe chronic renal failure (creatinine clearance < to 30 ml/min)

5. Mental disability of the subject making participation in the trial impossible

6. Patient not affiliated to a social security system

7. Inability to understand or sign informed consent

8. Serious adverse events

9. Early termination of participation, withdrawal of voluntary informed consent of the patient

10. Violation of protocol

Study & Design

• Study Type: Interventional
• Study Design: Not specified